IE821458L - SUBSTITUTED IMIDAZO £1,5-a| PYRIDINES - Google Patents
SUBSTITUTED IMIDAZO £1,5-a| PYRIDINESInfo
- Publication number
- IE821458L IE821458L IE821458A IE145882A IE821458L IE 821458 L IE821458 L IE 821458L IE 821458 A IE821458 A IE 821458A IE 145882 A IE145882 A IE 145882A IE 821458 L IE821458 L IE 821458L
- Authority
- IE
- Ireland
- Prior art keywords
- pyridines
- carbon atoms
- lower alkyl
- substituted imidazo
- compounds
- Prior art date
Links
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108010069102 Thromboxane-A synthase Proteins 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/32—Compounds having groups or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention concerns compounds with thromboxane synthetase inhibitory effects of the formula I <IMAGE> or 5,6,7,8-tetrahydro derivatives thereof, wherein each of R1 and R2 is hydrogen, halogen or lower alkyl; A is alkylene of 1 to 12 carbon atoms, alkynylene or alkenylene of 2 to 12 carbon atoms; B represents carboxy, lower alkoxycarbonyl, unsubstituted, mono- or di-(lower alkyl) substituted carbamoyl, cyano or hydroxymethyl; or salts thereof; and a process for the production of these compounds.
[EP0068386A1]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27609481A | 1981-06-22 | 1981-06-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE821458L true IE821458L (en) | 1982-12-22 |
| IE53396B1 IE53396B1 (en) | 1988-11-09 |
Family
ID=23055137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1458/82A IE53396B1 (en) | 1981-06-22 | 1982-06-21 | Substituted imidazo(1,5-a)pyridines,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0068386B1 (en) |
| JP (1) | JPS58979A (en) |
| KR (1) | KR890002640B1 (en) |
| AR (1) | AR242032A1 (en) |
| AT (1) | ATE17004T1 (en) |
| AU (1) | AU559666B2 (en) |
| CA (1) | CA1250844A (en) |
| DE (1) | DE3268010D1 (en) |
| DK (1) | DK158227C (en) |
| ES (5) | ES513307A0 (en) |
| FI (1) | FI75569C (en) |
| GB (1) | GB2101595B (en) |
| GR (1) | GR76844B (en) |
| HU (1) | HU190701B (en) |
| IE (1) | IE53396B1 (en) |
| IL (1) | IL66101A (en) |
| NO (1) | NO159276C (en) |
| NZ (1) | NZ201023A (en) |
| PT (1) | PT75084B (en) |
| ZA (1) | ZA824355B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| DE3373467D1 (en) * | 1982-06-14 | 1987-10-15 | Takeda Chemical Industries Ltd | Vinyl carboxylic acid derivatives, their production and use |
| US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
| US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
| ES2036128B1 (en) * | 1991-07-10 | 1993-12-16 | Menarini Lab | PROCEDURE FOR THE PREPARATION OF 4- (IMIDAZO) 1,5-A) PIRIDIN-8L) -1,4-DIHIDROPIRIDINAS. |
| US5468757A (en) * | 1994-01-31 | 1995-11-21 | Eli Lilly And Company | 6-azaindole thromboxane synthase inhibitors |
| CN100447142C (en) * | 2002-11-18 | 2008-12-31 | 诺瓦提斯公司 | Imidazo[1,5A]pyridine derivatives and methods of treating aldosterone-mediated diseases |
| JP5612860B2 (en) | 2007-03-09 | 2014-10-22 | プロビオドルグ エージー | Imidazo [1,5-a] pyridine derivatives as glutaminyl cyclase inhibitors |
-
1982
- 1982-06-18 GB GB08217704A patent/GB2101595B/en not_active Expired
- 1982-06-18 CA CA000405476A patent/CA1250844A/en not_active Expired
- 1982-06-18 FI FI822199A patent/FI75569C/en not_active IP Right Cessation
- 1982-06-21 GR GR68489A patent/GR76844B/el unknown
- 1982-06-21 KR KR8202756A patent/KR890002640B1/en not_active Expired
- 1982-06-21 DK DK277682A patent/DK158227C/en not_active IP Right Cessation
- 1982-06-21 PT PT75084A patent/PT75084B/en not_active IP Right Cessation
- 1982-06-21 IL IL66101A patent/IL66101A/en not_active IP Right Cessation
- 1982-06-21 AT AT82105426T patent/ATE17004T1/en not_active IP Right Cessation
- 1982-06-21 NO NO822062A patent/NO159276C/en unknown
- 1982-06-21 NZ NZ201023A patent/NZ201023A/en unknown
- 1982-06-21 AU AU85067/82A patent/AU559666B2/en not_active Ceased
- 1982-06-21 DE DE8282105426T patent/DE3268010D1/en not_active Expired
- 1982-06-21 ZA ZA824355A patent/ZA824355B/en unknown
- 1982-06-21 EP EP82105426A patent/EP0068386B1/en not_active Expired
- 1982-06-21 IE IE1458/82A patent/IE53396B1/en not_active IP Right Cessation
- 1982-06-21 HU HU822011A patent/HU190701B/en not_active IP Right Cessation
- 1982-06-21 ES ES513307A patent/ES513307A0/en active Granted
- 1982-06-22 JP JP57106292A patent/JPS58979A/en active Granted
-
1983
- 1983-09-16 ES ES525687A patent/ES525687A0/en active Granted
- 1983-09-16 ES ES525689A patent/ES525689A0/en active Granted
- 1983-09-16 ES ES525688A patent/ES8502996A1/en not_active Expired
- 1983-09-16 ES ES525686A patent/ES525686A0/en active Granted
-
1984
- 1984-01-19 AR AR84295476A patent/AR242032A1/en active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE821515L (en) | Imidazopyridines and imidazopyrazines | |
| IE810108L (en) | IMIDAZO £1,2-a| PYRIDINES | |
| GEP19960641B (en) | Process for production of [3h]-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one derivatives | |
| IE821458L (en) | SUBSTITUTED IMIDAZO £1,5-a| PYRIDINES | |
| ES8503686A1 (en) | Penicillin derivatives and process for preparation of the same. | |
| IE45700L (en) | PYRAZOLO (3,4-b) PYRIDINES | |
| IE831648L (en) | Cephalosporin compounds | |
| MY104455A (en) | Preparation of 1,4-diazabicyclo [3.2.2] nonane. | |
| DE3167449D1 (en) | Process for the production of heterocyclic substituted derivatives of 4-oxyphenoxy-alkane-carbonic acid | |
| EP0050671A4 (en) | THIAZOLO(3,2-a)PYRIMIDINE DERIVATIVES, PROCESS FOR PREPARING SAME, AND DRUG CONTAINING SAME. | |
| GB1346710A (en) | Antibacterial compositions | |
| ES8304971A1 (en) | Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives. | |
| IE821350L (en) | TETRAHYDRO-PYRAZOLO £4,3-e|-PYRIDO £3,2-b| £1, 4|¹DIAZEPAN-10-ONES | |
| HUT34752A (en) | Process for producing 2-amino-1,2,4-triazolo-/1,5-c/pyrimidine derivatives substituted at the 5 position | |
| JPS5742690A (en) | Thieno 3,2-b pyridinecarboxylic acid derivative | |
| HK6289A (en) | Furo-(3,4-c)-pyridine derivatives | |
| ES8308870A1 (en) | 5-(4-Phenyl-1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives. | |
| IE791184L (en) | IMIDAZO £1,2-a| IMIDAZOLE DERIVATIVES | |
| JPS51122093A (en) | A process for preparing novel pyrid (4,3-d) pyrimidine derivatives | |
| IL86665A0 (en) | Mitomycin analogs | |
| JPS5214799A (en) | Process for preparing 2-alkyl-3-acyl- pyrazolo(1,5-a) pyridine derivat ives | |
| AU3397789A (en) | Imidazo(1,2-a)furo-and thieno pyridine derivatives | |
| CA2010336A1 (en) | Process for producing pyrido[1,2-a]pyrimidine derivative | |
| JPS55143990A (en) | Preparation of novel diamine derivative, and thienodiazepin-2-one derivative containing the same | |
| JPS51136695A (en) | Process for preparing new pyrimido(4,5-d)pyrimidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |